Why Your Omega-6:Omega-3 Ratio Affects Your Heart Health

Cardiovascular disease kills approximately 18 million people per year globally — more than any other cause of death. Yet its primary risk factors are almost entirely dietary and lifestyle-modifiable. Among the nutritional factors linked to cardiovascular disease, the omega-6:omega-3 ratio stands out for both the strength of the evidence and the degree to which it is ignored in mainstream dietary advice.

The Simopoulos (2002) Research

The foundational paper is Artemis Simopoulos's 2002 review, "The importance of the ratio of omega-6/omega-3 essential fatty acids," published in Biomedicine & Pharmacotherapy. Simopoulos, then at the Center for Genetics, Nutrition and Health in Washington DC, synthesised evidence from multiple clinical trials and population studies to establish the importance of the ratio.

Key findings from this review:

The Lyon Diet Heart Study randomised 605 patients who had survived a myocardial infarction to either a Mediterranean-style diet (high oleic acid and ALA omega-3, low linoleic acid) or a standard post-infarction diet. After a mean follow-up of 27 months, the Mediterranean group had a 72% reduction in cardiac deaths and non-fatal infarctions. This is one of the largest effect sizes ever observed in a dietary intervention trial.

The Mediterranean diet in this study achieved an omega-6:omega-3 ratio of approximately 4:1 — compared to a Western average then estimated at 15–17:1.

GISSI-Prevenzione Trial: This Italian trial randomised 11,324 patients post-MI to omega-3 supplementation (EPA+DHA, 1g daily) or control. After 3.5 years, the omega-3 group showed a 20% reduction in total mortality, a 30% reduction in cardiovascular mortality, and a 45% reduction in sudden death. The magnitude of the sudden death reduction was particularly striking.

Greenland Inuit Populations: Research by Bang and Dyerberg in the 1970s–1980s observed remarkably low rates of cardiovascular disease in Greenland Inuit populations despite a diet extremely high in total fat. The key distinction was the fat composition: predominantly EPA and DHA from marine mammals and fish, with a very low omega-6:omega-3 ratio.

How Omega-3 Protects the Heart

The cardiovascular protection from omega-3 is mediated through multiple mechanisms:

Triglyceride Reduction

EPA and DHA reliably reduce circulating triglycerides by 15–30% in most studies, particularly at doses of 2–4g EPA+DHA daily. Elevated triglycerides are an independent cardiovascular risk factor.

Anti-Thrombotic Effects

EPA-derived thromboxane A3 is weakly platelet-aggregating, in contrast to AA-derived thromboxane A2 (strongly aggregating). Higher EPA:AA ratios therefore reduce the tendency of platelets to clump, lowering the risk of clot formation in narrowed arteries.

Anti-Arrhythmic Effects

DHA is incorporated into cardiac cell membranes, where it affects ion channel function. This may partially explain the dramatic reduction in sudden cardiac death (which is typically arrhythmic in origin) seen in the GISSI-Prevenzione trial.

Vascular Inflammation Reduction

EPA and DHA reduce production of pro-inflammatory cytokines (IL-6, TNF-α) by macrophages and reduce expression of adhesion molecules on vascular endothelium. Adhesion molecule expression facilitates the accumulation of macrophages in arterial plaques — a key step in atherosclerosis progression.

How Omega-6 Excess May Harm the Heart

The omega-6 side of the ratio has its own cardiovascular mechanisms:

Thromboxane A2 Production

AA-derived thromboxane A2 promotes platelet aggregation and vasoconstriction. Higher dietary omega-6 increases the AA content of platelet membrane phospholipids, priming platelets for more vigorous aggregation.

Oxidised LDL and Atherosclerosis

Linoleic acid-rich LDL particles are more susceptible to oxidation than oleic acid-rich LDL. Oxidised LDL is the form recognised by macrophage scavenger receptors in arterial walls — it is the oxidised LDL that is taken up and forms the foam cells characteristic of early atherosclerotic lesions.

The MESA study (Multi-Ethnic Study of Atherosclerosis) found associations between oxidised LA metabolites in plasma (OXLAMs) and markers of subclinical cardiovascular disease.

Leukotriene Production

AA-derived leukotriene B4 is a potent pro-inflammatory cytokine involved in recruiting neutrophils and macrophages to sites of vascular injury. Higher AA:EPA ratios in tissue phospholipids are associated with higher leukotriene B4 production.

The Role of the Ratio Specifically

A crucial distinction: the cardiovascular benefits of omega-3 supplementation are consistently larger in studies where baseline omega-3 status is low — that is, where the pre-intervention ratio is high.

Studies that found neutral or small effects from omega-3 supplementation (such as some ASCEND trial analyses) often involved populations who already consumed more fish than the average Western population, or who were on statin therapy that modified some of the same inflammatory pathways.

This strongly suggests that the ratio itself — not simply the absolute omega-3 intake — is the relevant variable. Improving a ratio from 20:1 to 10:1 produces larger benefits than improving a ratio from 6:1 to 4:1, even if the absolute omega-3 increase is the same.

What This Means Practically

The research supports a two-sided strategy for cardiovascular risk reduction via fatty acid management:

Reduce omega-6 intake:

1. Switch cooking oil from sunflower/vegetable to olive or avocado oil
2. Reduce packaged and fried foods (primary sources of hidden seed oil)
3. Read labels for soybean and sunflower oil in products

Increase omega-3 intake:

1. Eat oily fish 2–3 times per week (salmon, mackerel, sardines, herring)
2. Consider daily EPA+DHA supplementation at 1,000–2,000mg
3. Use olive oil rather than seed oil (lower omega-6 makes omega-3 intake more effective)

The dose-response relationship in the data suggests that even modest improvements in ratio — from a typical Western 20:1 to 10:1 — are likely to produce meaningful cardiovascular benefit. The optimal target of 4:1 or below represents a longer-term goal for those motivated to pursue it.

How to Assess Your Own Cardiovascular Risk from Omega Ratio

Short of a blood test, the calculator on this site provides a reasonable estimate of your omega-6:omega-3 ratio from dietary inputs. Blood-based tests that can precisely measure your ratio include:

• Omega-3 Index — measures EPA+DHA as a percentage of total fatty acids in red blood cell membranes. An index of 8% or above is associated with low cardiovascular risk; below 4% is high risk.
• Plasma fatty acid profile — broader measure of all fatty acids in plasma.

These tests are available from specialist nutrition laboratories and are increasingly offered by GP practices with nutritional medicine interest.

Most people don't need a blood test to know their ratio is likely too high — the calculator provides a practical starting point for understanding where you are and what to change.